Company Legal Name
Latest Valuation
Founded Year
Headquarter
Opentrons Labworks, Inc. develops liquid handling robots and software that automate laboratory workflows including pipetting and PCR setup. Founded in 2014 and headquartered in the United States, the company has positioned itself as a democratizing force in lab automation by offering accessible, open-source solutions that traditionally required expensive, proprietary equipment. Opentrons' platform enables researchers across academic institutions, biotechnology companies, and pharmaceutical organizations to standardize protocols, reduce human error, and increase throughput in their laboratory operations. The company continues to focus on expanding its automation capabilities and growing its user community through hardware innovation and software development.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





